13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001841857
Total reported value
$157.4M
$157.4M
57 檔
15.5%
The Q4 2024 SEC filing reveals that CM Management, LLC held a total portfolio value of $157.4M, covering 57 public equity positions.
During Q4 2024, CM Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including ALCO, RLGT, TGB) accounted for 15.5% of total reported equity market value during Q4 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALCO | Alico Inc | Stock-Other | 5.21% | -1.64% | — | |
| 2 | RLGT | Radiant Logistics Inc | Stock-Other | 4.64% | -0.10% | — | |
| 3 | TGB | Taseko Mines LTD | Stock-Other | 4.24% | — | — | |
| 4 | CLPT | Clearpoint Neuro Inc | Stock-Other | 3.98% | +0.28% | -3.33% | |
| 5 | AM6 | Amicus Therapeutics Inc | Stock-Other | 3.79% | — | — | |
| 6 | RPRX | Royalty Pharma plc | Stock-Healthcare | 3.65% | -0.56% | — | |
| 7 | RIGL | Rigel Pharmaceuticals Inc | Stock-Other | 3.64% | +0.90% | -16.38% | |
| 8 | NMRK | Newmark Group Inc-class A | Stock-Other | 3.43% | -0.46% | — | |
| 9 | PLPC | Preformed Line Products Co | Stock-Other | 3.08% | — | — | |
| 10 | TALO | Talos Energy Inc | Stock-Other | 3.03% | +0.62% | NEW | |
| 11 | ARKO | Arko CORP | Stock-Other | 2.89% | +0.05% | +2.94% | |
| 12 | INTT | Intest CORP | Stock-Other | 2.80% | -3.77% | EXIT | |
| 13 | CHRS | Coherus Oncology Inc | Stock-Other | 2.53% | -1.10% | +2.50% | |
| 14 | PD | Pagerduty Inc | Stock-Other | 2.45% | +0.23% | — | |
| 15 | CPA | Copa Holdings, S.A. | Stock-Other | 2.35% | +0.95% | +71.43% | |
| 16 | SABR | Sabre CORP | Stock-Tech | 2.28% | -0.02% | +7.69% | |
| 17 | BGC | Bgc Group Inc-a | Stock-Financials | 2.22% | -0.62% | — | |
| 18 | VTRS | Viatris Inc | Stock-Healthcare | 2.22% | -0.21% | — | |
| 19 | RBCAA | Republic Bancorp Inc-class A | Stock-Other | 2.18% | -0.05% | — | |
| 20 | OGN | Organon & Co | Stock-Healthcare | 2.00% | +0.36% | +50.00% | |
| 21 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 1.98% | -0.13% | +20.00% | |
| 22 | ARKR | Ark Restaurants CORP | Stock-Other | 1.96% | -0.39% | — | |
| 23 | BB3 | Brookline Bancorp Inc | Stock-Other | 1.90% | — | -20.00% | |
| 24 | PK | Park Hotels & Resorts Inc | Stock-Real Estate | 1.88% | -0.39% | — | |
| 25 | CGAU | Centerra Gold Inc | Stock-Other | 1.78% | — | — | |
| 26 | THFF | First Financial CORP | Stock-Other | 1.75% | -1.59% | EXIT | |
| 27 | ABX | Barrick Gold CORP | Stock-Financials | 1.73% | — | — | |
| 28 | FCX | Freeport-mcmoran Inc | Stock-Materials | 1.70% | — | +66.67% | |
| 29 | COHU | Cohu Inc | Stock-Other | 1.67% | — | +16.67% | |
| 30 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 1.65% | — | -25.00% | |
| 31 | EOLS | Evolus Inc | Stock-Other | 1.48% | +0.39% | — | |
| 32 | PAAS | Pan American Silver CORP | Stock-Materials | 1.44% | — | +60.00% | |
| 33 | XOMA | Xoma Royalty Corporation | Stock-Other | 1.29% | -1.05% | EXIT | |
| 34 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 1.15% | — | — | |
| 35 | WBA | Walgreens Boots Alliance Inc | Stock-Other | 1.04% | — | -37.50% | |
| 36 | SVC | Service Properties Trust | Stock-Other | 1.02% | -0.19% | +50.00% | |
| 37 | ELDN | Eledon Pharmaceuticals Inc | Stock-Other | 1.01% | -0.23% | — | |
| 38 | CVS | Cvs Health CORP | Stock-Healthcare | 1.00% | — | -28.57% | |
| 39 | HAS | Hasbro Inc | Stock-Consumer Disc | 1.00% | — | — | |
| 40 | HRTX | Heron Therapeutics Inc | Stock-Other | 0.96% | -0.40% | +40.00% | |
| 41 | DIT | Amcon Distributing Co | Stock-Other | 0.95% | -0.40% | — | |
| 42 | AVIR | Atea Pharmaceuticals Inc | Stock-Other | 0.90% | -0.55% | +11.11% | |
| 43 | COYA | Coya Therapeutics Inc | Stock-Other | 0.82% | +0.25% | +11.07% | |
| 44 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 0.66% | — | -60.00% | |
| 45 | NKTREUR | Nektar Therapeutics | Stock-Other | 0.62% | — | — | |
| 46 | CRIS | Curis Inc | Stock-Other | 0.60% | +0.11% | +83.33% | |
| 47 | LTRN | Lantern Pharma Inc | Stock-Other | 0.57% | +1.03% | +8.11% | |
| 48 | CTSO | Cytosorbents CORP | Stock-Other | 0.57% | -0.35% | -12.50% | |
| 49 | OSTX | Os Therapies Inc | Stock-Other | 0.42% | +0.01% | +120.09% | |
| 50 | ✓ | Femasys Inc | Stock-Other | 0.42% | — | — |
According to official SEC Form 13F filings, CM Management, LLC reported a total U.S. public equity portfolio value of $157.4M across 57 disclosed positions in Q4 2024.
During Q4 2024, CM Management, LLC's top holdings by market value included ALCO (5.2%)、RLGT (4.6%)、TGB (4.2%). The largest single position, ALCO, represented 5.2% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q4 2024, CM Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.